Dmitry Karshtedt is quoted by MarketWatch about patent litigation related to biosimilar drugs.
"These Drugs Could Cut American Health Costs by $250 Billion (If Only We Could Take Them)"
July 20, 2016
Dmitry Karshtedt is quoted by MarketWatch about patent litigation related to biosimilar drugs.